These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25126490)

  • 1. Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD).
    Alkhouri N; Eng K; Lopez R; Nobili V
    Springerplus; 2014; 3():407. PubMed ID: 25126490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 4. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.
    Alkhouri N; Tamimi TA; Yerian L; Lopez R; Zein NN; Feldstein AE
    Dig Dis Sci; 2010 Sep; 55(9):2644-50. PubMed ID: 19960252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.
    Corey KE; Vuppalanchi R; Vos M; Kohli R; Molleston JP; Wilson L; Unalp-Arida A; Cummings OW; Lavine JE; Chalasani N;
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):360-7. PubMed ID: 25714579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL flux is higher in patients with nonalcoholic fatty liver disease.
    McCullough A; Previs SF; Dasarathy J; Lee K; Osme A; Kim C; Ilchenko S; Lorkowski SW; Smith JD; Dasarathy S; Kasumov T
    Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E852-E862. PubMed ID: 31503515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects.
    Newfield RS; Graves CL; Newbury RO; Schwimmer JB; Proudfoot JA; Say DS; Feldstein AE
    Pediatr Diabetes; 2019 Feb; 20(1):41-47. PubMed ID: 30467936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH.
    Hegazy M; Saleh SA; Ezzat A; Behiry ME
    Diabetes Metab Syndr Obes; 2020; 13():297-305. PubMed ID: 32104026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH.
    Gottlieb A; Leven AS; Sowa JP; Borucki K; Link A; Yilmaz E; Aygen S; Canbay A; Porsch-Özcürümez M
    Digestion; 2021; 102(5):671-681. PubMed ID: 33080603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis.
    Corey KE; Lai M; Gelrud LG; Misdraji J; Barlow LL; Zheng H; Andersson KL; Thiim M; Pratt DS; Chung RT
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):651-6. PubMed ID: 22330232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
    Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease.
    Tabbaa A; Shaker M; Lopez R; Hoshemand K; Nobili V; Alkhouri N
    Pediatr Gastroenterol Hepatol Nutr; 2015 Sep; 18(3):168-74. PubMed ID: 26473136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.
    Goh GB; Pagadala MR; Dasarathy J; Unalp-Arida A; Sargent R; Hawkins C; Sourianarayanane A; Khiyami A; Yerian L; Pai RK; Dasarathy S; McCullough AJ
    BBA Clin; 2015 Jun; 3():141-5. PubMed ID: 26675585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis.
    Crudele L; De Matteis C; Piccinin E; Gadaleta RM; Cariello M; Di Buduo E; Piazzolla G; Suppressa P; Berardi E; Sabbà C; Moschetta A
    JHEP Rep; 2023 Jan; 5(1):100627. PubMed ID: 36561127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor.
    Konishi K; Miyake T; Furukawa S; Senba H; Kanzaki S; Nakaguchi H; Yukimoto A; Nakamura Y; Watanabe T; Koizumi Y; Yoshida O; Tokumoto Y; Hirooka M; Kumagi T; Abe M; Matsuura B; Hiasa Y
    Atherosclerosis; 2020 Apr; 299():32-37. PubMed ID: 32203743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.
    Sonmez A; Nikolic D; Dogru T; Ercin CN; Genc H; Cesur M; Tapan S; Karslioğlu Y; Montalto G; Banach M; Toth PP; Bagci S; Rizzo M
    J Clin Lipidol; 2015; 9(4):576-82. PubMed ID: 26228676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased atherogenic lipoprotein profile in children with non-alcoholic steatohepatitis.
    Castillo-Leon E; Connelly MA; Konomi JV; Caltharp S; Cleeton R; Vos MB
    Pediatr Obes; 2020 Sep; 15(9):e12648. PubMed ID: 32367624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.